Alliance A Phase II Study of Cabozantinib in Combination with Cemiplimab (REGN2810) (Cabo-Cemiplimab (REGN2810)) versus Cabozantinib Alone in Adolescents and Adults with Advanced Adrenocortical Cancer Adult CIRB - Late Phase Emphasis Active Available to Open